Vismodegib dose reduction effective when combined with itraconazole for the treatment of advanced basal cell carcinoma
Saved in:
Main Author: | Jaeyoung Yoon, MD, PhD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intracranial regression of an advanced basal cell carcinoma using sonidegib and itraconazole after failure with vismodegib
by: Jaeyoung Yoon, MD, PhD, et al.
Published: (2018) -
Vismodegib: A smoothened inhibitor for the treatment of advanced basal cell carcinoma
by: Suruchi Aditya, et al.
Published: (2013) -
Granulation tissue masquerading as basal cell carcinoma after treatment with vismodegib
by: Jayson Miedema, MD, et al.
Published: (2018) -
Metastatic same-site squamous cell carcinoma arising during vismodegib therapy for basal cell carcinoma
by: Raymond Zhao, BS, et al.
Published: (2022) -
Benefit-risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma
by: Antonio J García Ruiz, et al.
Published: (2022)